Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive alternative to glasses or surgery. Phase 3 trials demonstrated superior ...
The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...
The biotech also raised $235 million in debt and equity funding to support marketing of the drop, which it claims to be an ...
LOS ANGELES--(BUSINESS WIRE)--A new study from Citrulabs, a leading clinical research organization, found that Droptics, the first-of-its-kind eye drop designed specifically for the digital generation ...
A first-in-human pilot trial suggests umbilical cord–derived mesenchymal stem cell eye drops may safely improve symptoms and ...
Scientists presented new research suggesting that eye drops may one day replace reading glasses for millions of adults with presbyopia, the age-related condition that makes it hard to see up close.
People with so-called "resting squint face" may seem like they are perpetually angry, but they may just be having trouble seeing. Focusing on close objects becomes increasingly difficult as people age ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results